Adalta Ltd (1AD) - Cash Flow Conversion Efficiency

Latest as of December 2025: 2.240x

Based on the latest financial reports, Adalta Ltd (1AD) has a cash flow conversion efficiency ratio of 2.240x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-489.87K ≈ $-346.61K USD) by net assets (AU$-218.66K ≈ $-154.71K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Adalta Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Adalta Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adalta Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Adalta Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adalta Ltd ranked by their cash flow conversion efficiency. See 1AD operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
JPMorgan Claverhouse Investment Trust Plc LSE:JCH	0.020x
Adya Inc V:ADYA	0.087x
Oi S.A SA:OIBR3	0.001x
Noronex Ltd AU:NRX	-2.126x
HLT Global Bhd KLSE:0188	-0.159x
Ecoslops SA PA:ALESA	0.259x
GIGLIO.COM S.P.A. O.N. F:5JR0	N/A
Marvel Biosciences Corp V:MRVL	0.049x

Annual Cash Flow Conversion Efficiency for Adalta Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adalta Ltd from 2013 to 2025. View Adalta Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-598.24K ≈ $-423.30K	AU$-2.94 Million ≈ $-2.08 Million	4.909x	+289.49%
2024-06-30	AU$2.03 Million ≈ $1.44 Million	AU$-5.26 Million ≈ $-3.72 Million	-2.590x	+3.59%
2023-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-5.13 Million ≈ $-3.63 Million	-2.687x	-253.48%
2022-06-30	AU$5.38 Million ≈ $3.81 Million	AU$-4.09 Million ≈ $-2.89 Million	-0.760x	-1.52%
2021-06-30	AU$6.39 Million ≈ $4.52 Million	AU$-4.78 Million ≈ $-3.38 Million	-0.749x	+52.93%
2020-06-30	AU$3.70 Million ≈ $2.62 Million	AU$-5.89 Million ≈ $-4.17 Million	-1.591x	-104.89%
2019-06-30	AU$7.49 Million ≈ $5.30 Million	AU$-5.82 Million ≈ $-4.12 Million	-0.776x	+19.51%
2018-06-30	AU$4.07 Million ≈ $2.88 Million	AU$-3.93 Million ≈ $-2.78 Million	-0.965x	-100.48%
2017-06-30	AU$7.75 Million ≈ $5.48 Million	AU$-3.73 Million ≈ $-2.64 Million	-0.481x	-334.96%
2016-06-30	AU$10.62 Million ≈ $7.51 Million	AU$-1.17 Million ≈ $-830.93K	-0.111x	+94.35%
2015-06-30	AU$705.89K ≈ $499.46K	AU$-1.38 Million ≈ $-978.16K	-1.958x	+73.76%
2014-06-30	AU$172.82K ≈ $122.28K	AU$-1.29 Million ≈ $-912.79K	-7.465x	-219.41%
2013-06-30	AU$283.92K ≈ $200.89K	AU$-663.54K ≈ $-469.50K	-2.337x	--

About Adalta Ltd

AU:1AD Australia Biotechnology

Market Cap

$6.31 Million

AU$8.92 Million AUD

Market Cap Rank

#28213 Global

#1458 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.37